Johnson & Johnson news

   Watch this stock
Showing stories 1 - 10 of about 113   

Articles published

JNJ 102.52 +0.87 (0.86%)
price chart
Johnson & Johnson Is Said to Win a Bid for the Cancer Drug Maker Pharmacyclics
Johnson & Johnson is said to have prevailed in a bidding contest for Pharmacyclics, the developer of a cancer drug that some analysts predict will eventually become one of the best-selling treatments for that disease.
Pharmacyclics: Johnson & Johnson Would Have Made Way More Sense  Barron's (blog)
J&J nears deal for cancer drugmaker  CNBC
Johnson & Johnson ordered to pay $5.7 million in California mesh trial
(Reuters) - A California jury on Thursday ordered Johnson & Johnson's Ethicon Inc unit to pay $5.7 million in the first trial over injuries blamed on the TVT Abbrevo, one of numerous transvaginal mesh products that are the subject of thousands of lawsuits.
Johnson & Johnson wins Hillsborough incentives
Johnson & Johnson (NYSE: JNJ) is the second publicly identified company to bring a job creation proposal before commissioners in less than a month.
Hillsborough OKs package to lure Johnson & Johnson  WTSP 10 News
Hillsborough OKs $2.1 million to bring Johnson & Johnson jobs  TBO.com
Johnson & Johnson to Sell Cordis Unit for Nearly $2 Billion
Johnson & Johnson said on Monday that it would sell its Cordis business, which makes vascular technology, to Cardinal Health for just under $2 billion.
Cardinal Health acquires Johnson & Johnson's Cordis in a $1.9B deal  The Deal Pipeline
Johnson & Johnson Announces Binding Offer from Cardinal Health to ...  PR Newswire (press release)
Johnson & Johnson (JNJ) Opens Biotech Incubator In South San Francisco ...
Johnson & Johnson opened a new biotech incubator in South San Francisco that will host 10 companies working to develop medical devices and pharmaceuticals in a "no strings attached" arrangement.
Johnson & Johnson opening another JLABS accelerator in South San Francisco  MedCity News
Peek inside Johnson & Johnson's new Bay Area life sciences incubator ...  Silicon Valley Business Journal (blog)
Hillsborough in hunt for up to 700 Johnson & Johnson jobs
Health care giant Johnson & Johnson, ranked 11th on Fortune's 2015 list of the world's most admired companies, is considering plans to invest up to $23.5 million to establish a "shared services headquarters operation" in Hillsborough County with as ...
Johnson & Johnson could bring 700 jobs to Tampa area  TBO.com
Johnson & Johnson near deal for Pharmacyclics: FT
SAN FRANCISCO (MarketWatch) -- Johnson & Johnson JNJ, -0.67% is near a deal for drugmaker Pharmacyclics Inc. PCYC, +6.33% the Financial Times reported Wednesday on its web site.
Johnson & Johnson Loses Trial Over Risperdal And Male Breasts
In a setback to Johnson & Johnson JNJ +0.79%, a Philadelphia jury decided the health care giant must pay $2.5 million in damages for failing to warn that its Risperdal antipsychotic could cause gynecomastia, which is abnormal development of breasts in ...
Johnson & Johnson loses first Risperdal jury trial  Philly.com
South Carolina court orders Johnson & Johnson to pay $136 million in ...  Reuters
There's A World Of Difference Between Johnson & Johnson And Procter & Gamble
Investors looking at large cap blue chip or dividend growth stocks continue to gravitate to names like Johnson & Johnson (NYSE:JNJ) and Procter & Gamble (NYSE:PG). Their impressive corporate and dividend histories, iconic brands, consumer ...
Traders Buy Johnson & Johnson on Weakness (JNJ)  WKRB News
Boston Scientific Will Pay Johnson & Johnson $600M
Boston Scientific will pay $600 million to settle with drugmaker Johnson & Johnson over the medical device maker's $27 billion acquisition of Guidant Corp.
Pharmalot, Pharmalittle: We're Reading About Pfizer, Johnson & ...  Wall Street Journal (blog)